| Pure Flow Processing, Sales | Number of Estimates | | 12 | 12 | 12 |
| Pure Flow Processing, Sales | Highest | | 2,109.0 | 2,232.0 | 2,349.0 |
| Pure Flow Processing, Sales | Consensus (Mean) | 1,953.1 | 2,071.5 | 2,179.1 | 2,278.4 |
| Pure Flow Processing, Sales | Median | | 2,071.3 | 2,168.2 | 2,272.3 |
| Pure Flow Processing, Sales | Lowest | | 2,046.7 | 2,134.0 | 2,220.0 |
| Pure Flow Processing, EBITDA before restructuring | Number of Estimates | | 11 | 11 | 11 |
| Pure Flow Processing, EBITDA before restructuring | Highest | | 585.0 | 626.0 | 665.0 |
| Pure Flow Processing, EBITDA before restructuring | Consensus (Mean) | 522.4 | 569.2 | 605.4 | 636.7 |
| Pure Flow Processing, EBITDA before restructuring | Median | | 569.1 | 605.2 | 633.5 |
| Pure Flow Processing, EBITDA before restructuring | Lowest | | 556.0 | 580.0 | 605.0 |
| Pure Flow Processing, EBITDA before restructuring margin in % | Number of Estimates | | 11 | 11 | 11 |
| Pure Flow Processing, EBITDA before restructuring margin in % | Highest | | 28.0 | 28.1 | 28.3 |
| Pure Flow Processing, EBITDA before restructuring margin in % | Consensus (Mean) | 26.7 | 27.5 | 27.8 | 27.9 |
| Pure Flow Processing, EBITDA before restructuring margin in % | Median | | 27.5 | 27.8 | 27.9 |
| Pure Flow Processing, EBITDA before restructuring margin in % | Lowest | | 27.0 | 27.2 | 27.3 |
| Nutrition Plant Engineering, Sales | Number of Estimates | | 12 | 12 | 12 |
| Nutrition Plant Engineering, Sales | Highest | | 2,144.0 | 2,278.0 | 2,428.6 |
| Nutrition Plant Engineering, Sales | Consensus (Mean) | 1,954.6 | 2,088.6 | 2,201.1 | 2,308.2 |
| Nutrition Plant Engineering, Sales | Median | | 2,093.9 | 2,208.0 | 2,303.4 |
| Nutrition Plant Engineering, Sales | Lowest | | 2,024.0 | 2,106.0 | 2,190.0 |
| Nutrition Plant Engineering, EBITDA before restructuring | Number of Estimates | | 11 | 11 | 11 |
| Nutrition Plant Engineering, EBITDA before restructuring | Highest | | 256.8 | 283.7 | 310.9 |
| Nutrition Plant Engineering, EBITDA before restructuring | Consensus (Mean) | 222.4 | 249.3 | 271.6 | 292.0 |
| Nutrition Plant Engineering, EBITDA before restructuring | Median | | 250.0 | 273.5 | 293.0 |
| Nutrition Plant Engineering, EBITDA before restructuring | Lowest | | 242.1 | 259.2 | 276.3 |
| Nutrition Plant Engineering, EBITDA before restructuring margin in % | Number of Estimates | | 11 | 11 | 11 |
| Nutrition Plant Engineering, EBITDA before restructuring margin in % | Highest | | 12.2 | 12.6 | 13.3 |
| Nutrition Plant Engineering, EBITDA before restructuring margin in % | Consensus (Mean) | 11.4 | 11.9 | 12.3 | 12.6 |
| Nutrition Plant Engineering, EBITDA before restructuring margin in % | Median | | 11.9 | 12.3 | 12.6 |
| Nutrition Plant Engineering, EBITDA before restructuring margin in % | Lowest | | 11.7 | 11.9 | 12.0 |
| Pharma & Food Applications, Sales | Number of Estimates | | 12 | 12 | 12 |
| Pharma & Food Applications, Sales | Highest | | 1,132.5 | 1,205.6 | 1,278.0 |
| Pharma & Food Applications, Sales | Consensus (Mean) | 1,058.3 | 1,117.3 | 1,164.5 | 1,225.9 |
| Pharma & Food Applications, Sales | Median | | 1,119.2 | 1,171.4 | 1,228.6 |
| Pharma & Food Applications, Sales | Lowest | | 1,092.0 | 1,093.1 | 1,136.8 |
| Pharma & Food Applications, EBITDA before restructuring | Number of Estimates | | 11 | 11 | 11 |
| Pharma & Food Applications, EBITDA before restructuring | Highest | | 172.8 | 185.0 | 200.0 |
| Pharma & Food Applications, EBITDA before restructuring | Consensus (Mean) | 140.7 | 165.5 | 175.8 | 190.0 |
| Pharma & Food Applications, EBITDA before restructuring | Median | | 165.0 | 176.1 | 195.7 |
| Pharma & Food Applications, EBITDA before restructuring | Lowest | | 160.0 | 158.5 | 176.2 |
| Pharma & Food Applications, EBITDA before restructuring margin in % | Number of Estimates | | 11 | 11 | 11 |
| Pharma & Food Applications, EBITDA before restructuring margin in % | Highest | | 15.4 | 15.6 | 16.2 |
| Pharma & Food Applications, EBITDA before restructuring margin in % | Consensus (Mean) | 13.3 | 14.8 | 15.1 | 15.5 |
| Pharma & Food Applications, EBITDA before restructuring margin in % | Median | | 14.7 | 15.1 | 15.5 |
| Pharma & Food Applications, EBITDA before restructuring margin in % | Lowest | | 14.2 | 14.2 | 14.4 |
| Farm Technologies, Sales | Number of Estimates | | 12 | 12 | 12 |
| Farm Technologies, Sales | Highest | | 869.0 | 900.7 | 967.1 |
| Farm Technologies, Sales | Consensus (Mean) | 763.4 | 838.2 | 875.3 | 912.5 |
| Farm Technologies, Sales | Median | | 831.9 | 873.4 | 908.3 |
| Farm Technologies, Sales | Lowest | | 822.0 | 847.0 | 881.1 |
| Farm Technologies, EBITDA before restructuring | Number of Estimates | | 11 | 11 | 11 |
| Farm Technologies, EBITDA before restructuring | Highest | | 140.0 | 150.0 | 164.4 |
| Farm Technologies, EBITDA before restructuring | Consensus (Mean) | 113.0 | 131.2 | 140.2 | 150.2 |
| Farm Technologies, EBITDA before restructuring | Median | | 131.0 | 141.6 | 149.9 |
| Farm Technologies, EBITDA before restructuring | Lowest | | 125.0 | 125.0 | 143.0 |
| Farm Technologies, EBITDA before restructuring margin in % | Number of Estimates | | 11 | 11 | 11 |
| Farm Technologies, EBITDA before restructuring margin in % | Highest | | 16.3 | 16.8 | 17.0 |
| Farm Technologies, EBITDA before restructuring margin in % | Consensus (Mean) | 14.8 | 15.7 | 16.1 | 16.5 |
| Farm Technologies, EBITDA before restructuring margin in % | Median | | 15.8 | 16.2 | 16.5 |
| Farm Technologies, EBITDA before restructuring margin in % | Lowest | | 15.1 | 14.2 | 15.9 |
| Consolidation/Other, Sales | Number of Estimates | | 12 | 12 | 12 |
| Consolidation/Other, Sales | Highest | | -180.0 | -234.0 | -234.0 |
| Consolidation/Other, Sales | Consensus (Mean) | -234.0 | -238.1 | -249.0 | -259.6 |
| Consolidation/Other, Sales | Median | | -239.0 | -240.6 | -248.7 |
| Consolidation/Other, Sales | Lowest | | -270.0 | -300.0 | -320.0 |
| Consolidation/Other, EBITDA before restructuring | Number of Estimates | | 11 | 11 | 11 |
| Consolidation/Other, EBITDA before restructuring | Highest | | -87.0 | -85.0 | -83.0 |
| Consolidation/Other, EBITDA before restructuring | Consensus (Mean) | -91.1 | -95.8 | -95.9 | -97.4 |
| Consolidation/Other, EBITDA before restructuring | Median | | -94.0 | -94.0 | -95.0 |
| Consolidation/Other, EBITDA before restructuring | Lowest | | -110.0 | -115.0 | -120.0 |